FULGENT GENETICS, INC. Notes Payable, Noncurrent
FULGENT GENETICS, INC. (FLGT) had Notes Payable, Noncurrent of $1.48 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermNotesPayable · last filed 2026-07-30
- 2026-06-30: Notes Payable, Noncurrent $1.48M.
- 2026-03-31: Notes Payable, Noncurrent $1.48M.
- 2025-12-31: Notes Payable, Noncurrent $1.96M.
- 2025-09-30: Notes Payable, Noncurrent $1.96M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2026-06-30 | $1.48M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $1.48M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $1.96M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $1.96M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.96M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $1.96M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $2.49M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.49M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.49M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $2.49M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $2.96M 10-K · filed 2025-02-28 |
| 2022-12-31 | $3.37M 10-K · filed 2024-02-28 |
| 2021-09-30 | $5.95M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.90M 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |